4.5 Article

A chimeric vaccine targeting Pseudomonas aeruginosa virulence factors protects mice against lethal infection

期刊

MICROBIAL PATHOGENESIS
卷 178, 期 -, 页码 -

出版社

ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.micpath.2023.106033

关键词

Pseudomonas aeruginosa; OprF; PcrV; Flagellin; Acute pneumonia

向作者/读者索取更多资源

The study shows that a chimeric vaccine including PcrV, FlaA, FlaB, and OprF (PABF) protein can induce a robust immune response, reduce bacterial burden, and improve survival after P. aeruginosa infection. It exhibits broad-spectrum immunity and holds promise as a candidate for treating and controlling P. aeruginosa infections.
Pseudomonas aeruginosa is an important and hazardous nosocomial pathogen in respiratory tract infections and rapidly achieves antibiotic resistance, so it is necessary to develop an effective vaccine to combat the infection. The Type III secretion system (T3SS) protein P. aeruginosa V-antigen (PcrV), outer membrane protein F (OprF), and two kinds of flagellins (FlaA and FlaB) all play important roles in the pathogenesis of P. aeruginosa lung infection and its spread into deeper tissues. In a mouse acute pneumonia model, the protective effects of a chimer vaccine including PcrV, FlaA, FlaB, and OprF (PABF) protein were investigated. PABF immunization prompted robust opsonophagocytic titer of IgG antibodies and decreased bacterial burden, and improved survival after-ward intranasal challenge with ten times 50% lethal doses (LD50) of P. aeruginosa strains, indicating its broad-spectrum immunity. Moreover, these findings showed a promise chimeric vaccine candidate to treat and control P. aeruginosa infections.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据